Overall rank by patents
#500
Across all tracked assignees
USPTO PatentsView assignee record - 892 granted patents across 142 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C07C (ACYCLIC OR CARBOCYCLIC COMPOUNDS).
The verdict
Arkema holds 892 US patents across 142 technology areas, rank #500 of 50,000 tracked assignees.
Arkema France has been granted 892 US utility patents between 2015 and 2025, placing Arkema France at rank #500 across all assignees tracked by PlainPatent. This portfolio spans 142 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.6 claims per patent with primary concentration in C07C (ACYCLIC OR CARBOCYCLIC COMPOUNDS). As a Foreign Corporation, Arkema France is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Arkema sits between Koito Manufacturing Co., Ltd. (902 patents, rank #496) and Epistar Corporation (889 patents, rank #504) - the closest US assignees by grant volume. The composite Innovation Score of 62.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 470 grants, compared with 422 in the 2015–2019 window, a +11% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Arkema France's 15.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Arkema France against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
KOITO MANUFACTURING CO., LTD.
902 patents
BAE Systems Information and Electronic Systems Integration Inc.
900 patents
OmniVision Technologies, Inc.
897 patents
GLOBALFOUNDRIES U.S. Inc.
896 patents
ARKEMA FRANCE
892 patents
Illumina, Inc.
890 patents
NISSAN NORTH AMERICA, INC.
890 patents
SHELL OIL COMPNY
890 patents
Epistar Corporation
889 patents
What this shows Arkema holds 892 patents at rank #500, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #500 in granted patent volume.
Other assignees with the most granted patents in Arkema's primary technology class.
Arkema's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
62 Top 2% higher than 98% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 63 | 7.1% |
| 2016 | 70 | 7.8% |
| 2017 | 76 | 8.5% |
| 2018 | 105 | 11.8% |
| 2019 | 108 | 12.1% |
| 2020 | 108 | 12.1% |
| 2021 | 95 | 10.7% |
| 2022 | 88 | 9.9% |
| 2023 | 58 | 6.5% |
| 2024 | 59 | 6.6% |
| 2025 | 62 | 7.0% |
Top 15 of 142 technology areas
Overall rank by patents
#500
Across all tracked assignees
62.2 out of 100
How to use this portfolio
Arkema's 892 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.